Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Cancers in the Thoracic Region”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Early research (Phase 1)Study completedNCT03518554
What this trial is testing

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 38
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT04919811
What this trial is testing

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Nuvation Bio Inc. 217
Early research (Phase 1)Looking for participantsNCT06505824
What this trial is testing

BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

Who this might be right for
Small Cell Lung CancerNeuroendocrine Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 22
Testing effectiveness (Phase 2)Looking for participantsNCT07169994
What this trial is testing

YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsBreast CancerNon Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 414
Not applicableStudy completedNCT04076228
What this trial is testing

Biomarkers to Predict the Response to Pembrolizumab in Chinese NSCLC Patients

Who this might be right for
NSCLC Stage IV
Kiang Wu Hospital 37
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 273
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472647
What this trial is testing

SYS6090 Combination Therapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung Cancer
Shanghai JMT-Bio Inc. 596
Early research (Phase 1)Looking for participantsNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 330
Early research (Phase 1)Study completedNCT03080311
What this trial is testing

APG-1252 in Patients With SCLC or Other Solid Tumors

Who this might be right for
Small Cell Lung CancerSolid Tumor
Ascentage Pharma Group Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT04198818
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Who this might be right for
Advanced TumorsMelanomaNon-Small-Cell Lung Cancer+2 more
Haihe Biopharma Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT06922591
What this trial is testing

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Who this might be right for
PDACPDAC - Pancreatic Ductal AdenocarcinomaNSCLC+5 more
Tango Therapeutics, Inc. 183
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Testing effectiveness (Phase 2)Study completedNCT00531284
What this trial is testing

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Who this might be right for
Ovarian CancerRenal CancerNon-small Cell Lung Cancer+4 more
Amgen 184
Not applicableStudy completedNCT00608452
What this trial is testing

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

Who this might be right for
Lung CancerOvarian CancerBreast Cancer+2 more
Memorial Sloan Kettering Cancer Center 121
Not applicableStudy completedNCT04939558
What this trial is testing

Cardiorespiratory Diagnostic Study

Who this might be right for
COPDAsthmaLung Cancer+7 more
TidalSense 744
Early research (Phase 1)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 100
Testing effectiveness (Phase 2)Looking for participantsNCT06475300
What this trial is testing

BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal CarcinomaSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Load More Results